Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Tipo de documento
Ano de publicação
Intervalo de ano de publicação
1.
Transpl Infect Dis ; 17(2): 303-7, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25645490

RESUMO

We present a case report of a patient with diffuse skin and systemic Kaposi's sarcoma (KS), 1 year after renal transplantation. A concomitant Pyrenochaeta romeroi granuloma of the right hallux was diagnosed and illustrated an important immunodysfunction in our patient. Four months after reduction in immunosuppression and switch to everolimus, a total regression of the KS was observed. Reduction in the immunosuppression and treatment with terbinafine cleared the P. romeroi infection, while lowering immunosuppression and changing the type of immunosuppressive therapy were important steps in the successful management of the KS. In recent years, evidence of the antitumor effects of everolimus is increasing: total regression of KS in combination with renal function preservation in renal graft recipients is possible with mammalian target of rapamycin (mTOR) inhibitor-based regimens. In addition, with increasing numbers of human immunodeficiency virus-positive transplant recipients, mTOR inhibitors may play a more crucial role in the management of KS.


Assuntos
Dermatomicoses/etiologia , Substituição de Medicamentos , Everolimo/uso terapêutico , Imunossupressores/efeitos adversos , Transplante de Rim , Neoplasias Hepáticas/etiologia , Sarcoma de Kaposi/etiologia , Neoplasias Cutâneas/etiologia , Adulto , Dermatomicoses/imunologia , Feminino , Rejeição de Enxerto/prevenção & controle , Humanos , Imunossupressores/uso terapêutico , Neoplasias Hepáticas/imunologia , Ácido Micofenólico/efeitos adversos , Ácido Micofenólico/análogos & derivados , Sarcoma de Kaposi/imunologia , Neoplasias Cutâneas/imunologia , Tacrolimo/efeitos adversos , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA